| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-16 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.28 | 5e-13 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |